Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | Efavirenz | HCID 64139 | — |
| Reactant | tert-Butyl 4-bromobutanoate | HCID 2757253 | — |
| Catalyst | 18-Crown-6 | HCID 28557 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 69494573 | HCID 69494573 | 91.3% |
Reaction Steps
To 250 mg (0.79 mmol) of efavirenz 1 was added 10 mL of anhydrous DMF, 600 mg (4.34 mmol) of potassium carbonate, 120 mg (0.80 mmol) of sodium iodide and 492 mg (2.2 mmol) of 4-bromo-butyric acid tert-butyl ester followed by 5 mg of 18-crown-6. The mixture was heated to 125° C. for 2 hours under argon atmosphere and concentrated under reduced pressure. To the residue 50 mL of chloroform was added, and the solid was filtered off. To the filtrate 50 mL of water was added. The organic layer was separated, washed with 50 mL of water, dried (Na2SO4), and concentrated. The residue was purified by silica gel flash column chromatography in 70% ethyl acetate in hexane to give 327 mg (0.721 mmol, 90% yield) of 2 (M+Na, 480).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07271252B2 |
|---|
| Source dataset | uspto-grants-2007_09 |
|---|
| ORD ID | ord-5157591713fa45adb5e84b453d9982ae |
|---|
| Source note | uspto-grants-2007_09 |
|---|